Home › Heart Failure › Texas › El Paso
Heart Failure clinical trials in El Paso, TX
6 studies for Heart Failure are looking for participants at sites in and around El Paso (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- David Turbay, MD, El Paso
CCM OPEN HF Registry
RecruitingObservational study
- David Turbay, MD, El Paso
- Texan Cardiovascular Institute, El Paso
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RecruitingPhase 3
- Research Site, El Paso
- Research Site, El Paso
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
RecruitingPhase 3
- Research Site, El Paso
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
RecruitingPhase 3
- Research Site, El Paso
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- Proactive El Paso LLC, El Paso
- David Turbay, MD, PLLC, El Paso
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA46 studies
- Dallas, TX42 studies
- Houston, TX35 studies
- Cleveland, OH31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- Chicago, IL28 studies
- Durham, NC25 studies
- Kansas City, MO25 studies
- St. Louis, MO24 studies
- Indianapolis, IN24 studies
Other studies in El Paso
- Obesity8 studies
- Breast Cancer7 studies
- Non-Small Cell Lung Cancer6 studies
- Overweight6 studies
- Metastatic Cancer5 studies
- COPD5 studies
- Idiopathic Pulmonary Fibrosis5 studies
- Burkitt Lymphoma4 studies
- Alzheimer's Disease4 studies
- Migraine4 studies
- Graves Disease4 studies
- Lupus4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.